-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/weingart-sn-et-al-2003
January 01, 2003 - Weingart SN et al. 2003 "Physicians' decisions to override computerized drug alerts in primary care."
Reference
Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163(21):2625-2631.
[Link]
Abstract
"Backgroun…
-
digital.ahrq.gov/sites/default/files/docs/activity/surveillance_for_adverse_drug_events_in_ambulatory_pediatrics_2010pdf_2.pdf
August 01, 2010 - Surveillance for Adverse Drug Events in Ambulatory Pediatrics
1 | Surveillance for adverSe drug eventS in ambulatory PediatricS
2010 Grant Summary
Surveillance for Adverse Drug Events in Ambulatory Pediatrics
Principal Investigator: Bailey, Thomas, M.D.
Organization: Washington University in St. Louis
Mechan…
-
digital.ahrq.gov/sites/default/files/docs/page/CORLEY_AHRQ_CDSC_5-29.pdf
April 20, 2013 - uses RxNorm for allergies
• First Data Bank does not provide RxNorm
mapping for allergies, only drugs
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/magnus-d-et-al-2002-gps
January 01, 2002 - Magnus D et al. 2002 "GPs' views on computerized drug interaction alerts: questionnaire survey."
Reference
Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002;27(5):377-382.
Abstract
"Background: There is evidence that…
-
digital.ahrq.gov/ahrq-funded-projects/surveillance-adverse-drug-events-ambulatory-pediatrics
January 01, 2023 - Surveillance for Adverse Drug Events in Ambulatory Pediatrics
Project Final Report ( PDF , 941.73 KB) Disclaimer
Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views …
-
digital.ahrq.gov/ahrq-funded-projects/prescription-drug-monitoring-program-integration-electronic-health-record
March 31, 2024 - Prescription Drug Monitoring Program Integration in the Electronic Health Record
Project Final Report ( PDF , 415.31 KB) Disclaimer
Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily rep…
-
digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/disproportionality
January 01, 2023 - A disproportionality analysis of drug-drug interactions of tizanidine and CYP1A2 inhibitors from the FDA Adverse Event Reporting System (FAERS).
Citation
Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD, Malone DC. A disproportionality analysis of drug-drug interactions of tizanidine and CY…
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs025375-zhou-final-report-2022.pdf
January 01, 2022 - We also created a hierarchy of causative drugs
based on a commercial knowledge base (i.e., First DataBank … We first classified drugs into corresponding drug classes using the American Hospital
Formulary Service … Finally, our cross-
reactivity logic was based on drug classes, not individual drugs. … Although data exist regarding
cross-reactivity of individual drugs, it remains an area of uncertainty … penicillins (14%),
opioids (10%), sulfonamide antibiotics (9%) and non-steroidal anti-inflammatory drugs
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
August 18, 2011 - Drug-drug interactions:
– interaction alerts were beneficial to patient safety
– Highly regarded for drugs
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-16
January 01, 2023 - Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.
Citation
Phansalkar S, van der Sijs H, Tucker AD, et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J Am Med …
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/citation/reduced
January 01, 2023 - Reduced effectiveness of interruptive drug-drug interaction alerts after conversion to a commercial electronic health record.
Citation
Wright A, Aaron S, Seger DL, et al. Reduced effectiveness of interruptive drug-drug interaction alerts after conversion to a commercial electronic health record. J Gen…
-
digital.ahrq.gov/ahrq-funded-projects/preventing-wrong-drug-and-wrong-patient-errors-indication-alerts-cpoe-systems
January 01, 2023 - Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems
Project Final Report ( PDF , 953.21 KB) Disclaimer
Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessaril…
-
digital.ahrq.gov/principal-investigator/ferranti-jeffrey
January 01, 2023 - Ferranti, Jeffrey
Sharing adverse drug event data using business intelligence technology.
Citation
Horvath MM, Cozart H, Ahmad A, et al. Sharing adverse drug event data using business intelligence technology. J Patient Saf 2009 Mar;5(1):35-41.
Principal Investigator
…
-
digital.ahrq.gov/2020-year-review/research-summary/anesthesiology-control-tower-air-traffic-control-operating-rooms
January 01, 2020 - collected during surgery—vital signs, heart rate, blood pressure, temperature, fluid administered, drugs
-
digital.ahrq.gov/principal-investigator/ratwani-raj-m
January 01, 2023 - Drugs & Therapy Perspectives; Auckland Vol. 38, Iss. 3, (Mar 2022): 146-155.
-
digital.ahrq.gov/ahrq-funded-projects/demonstration-project-assessing-significance-and-impact-utilizing-novel
January 01, 2023 - illness, the natural aging process, and multiple-drug treatment—affect their ability to metabolize drugs
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/hunt-dl-et-al-1998
January 01, 1998 - Functions were varied but included drug dosing - particularly for intravenous drugs, patient diagnosis
-
digital.ahrq.gov/sites/default/files/docs/page/e_prescribing_in_medicaid_chip_agencies__implementation_approaches__challenges__and_opportunities_summary_5.pdf
October 01, 2009 - if 70% of prescriptions for
Medicaid patients are electronically prescribed
(excluding scheduled drugs … • Better Visibility—The physician can see interactions for
all drugs the patient is using regardless
-
digital.ahrq.gov/sites/default/files/docs/publication/p20hs015325-hartzema-final-report-2005.pdf
January 01, 2005 - Automated dispensing cabinets are machines that allow drugs to be dispensed at
the point of care, and … Another positive aspect of automated dispensing cabinets is the limited access to drugs in general and … to
narcotic drugs in particular. … A5: can configure dispensing only to release pharmacist approved drugs, or can allow certain staff to … Accreditation and Other
Considerations
n 24hr/7day concurrent Rx review
n Controlled access to pharmaceuticals
-
digital.ahrq.gov/principal-investigator/bailey-thomas
January 01, 2023 - Bailey, Thomas
Natural language processing to identify adverse drug events.
Citation
Gysbers M, Reichley R, Kilbridge PM, et al. Natural language processing to identify adverse drug events. AMIA Annu Symp Proc 2008 Nov 6:961.
Principal Investigator
Bailey, Thomas
…